- Home
- CTOS vs MLTX Comparison
CTOS vs MLTX Comparison
Compare CTOS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTOS | MLTX |
|---|---|---|
| Founded | 1988 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CTOS | MLTX |
|---|---|---|
| Price | $6.56 | $14.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $7.50 | ★ $22.22 |
| AVG Volume (30 Days) | 793.9K | ★ 3.5M |
| Earning Date | 03-03-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,936,513,000.00 | N/A |
| Revenue This Year | $13.19 | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.39 | N/A |
| 52 Week Low | $3.18 | $5.95 |
| 52 Week High | $6.80 | $62.75 |
Technical Indicators
Market Signals| Indicator | CTOS | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.15 | 44.57 |
| Support Level | $6.17 | $15.62 |
| Resistance Level | $6.80 | $16.69 |
| Average True Range (ATR) | 0.22 | 0.92 |
| MACD | 0.01 | -0.22 |
| Stochastic Oscillator | 59.91 | 1.58 |
Price Performance
Historical ComparisonAbout CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.